학술논문

A Phase I Trial of Activated Donor-Derived Marrow Infiltrating Lymphocytes to Treat Relapsed Hematologic Malignancies after Allogeneic Transplantation with PostTransplantation Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis